Status:
UNKNOWN
Technology-Enhanced Executive Functioning Intervention for ADHD
Lead Sponsor:
Children's National Research Institute
Conditions:
ADHD
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
11-14 years
Phase:
PHASE1
Brief Summary
This study develops and refines an online platform that will support clinician-directed behavioral and organizational skills intervention for adolescents with Attention-Deficit/Hyperactivity Disorder ...
Detailed Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common childhood mental health disorders, affecting 7-9% of youth and leading to substantial impairment in adolescence. Despite evide...
Eligibility Criteria
Inclusion
- Youth ages of 11 to 14 that are attending a participating school
- referred by school mental health provider as a youth with apparent ADHD-related problems
- ≥6 symptoms (item score ≥2) of Inattention or Hyperactivity-Impulsivity on the pooled parent and teacher Vanderbilt ADHD Rating Scale
- ≥3 on the Impairment Rating Scale by parent and teacher (cross-situational impairment)
- Parent consent and youth assent must be provided
Exclusion
- No presence of conditions that are incompatible with this study's treatment including: Parent or adolescent report of a prior diagnosis of either Autism Spectrum Disorder, Bipolar Disorder, a Dissociative Disorder, Severe visual or hearing impairment, severe language delay or intellectual impairment, or a Psychotic Disorder will be excluded. Rationale: Individuals with these disorders often have very dysregulated behavior and impairments that deviate from the focus of this study.
- Adolescent is in all-day special education classes or if core classes not in regular education classrooms. Rationale: The vast majority of adolescent with ADHD are served in regular education classrooms and students in full-day self-contained classrooms often have different challenges than students in regular education.
- Adolescent planning to change (start or stop) psychotropic medication. Note: Adolescents taking medication will be required to meet all entry criteria, including impairment criteria, thus indicating a need for the intervention. Adolescent taking medication for attention or behavior are eligible as long as their medication regimens are stable. Participating parents will also need to be able to read/speak English because all measures are in English, and the intervention will be conducted in English.
Key Trial Info
Start Date :
February 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 14 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04729439
Start Date
February 3 2021
End Date
November 14 2024
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Research Institute
Washington D.C., District of Columbia, United States, 20010